UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target

Pharmaceutics, 2017-02, Vol.9 (1), p.9

2017

Volltextzugriff (PDF)

S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy

Drug metabolism and disposition, 2018-08, Vol.46 (8), p.1157-1168

2018

Volltextzugriff (PDF)

Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms

Medical hypotheses, 2020-11, Vol.144, p.110033-110033, Article 110033

2020

Volltextzugriff (PDF)

Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats

Food and chemical toxicology, 2018-01, Vol.111, p.650-659

2018

Volltextzugriff (PDF)

Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states

Chemico-biological interactions, 2019-02, Vol.299, p.140-150

2019

Volltextzugriff (PDF)

Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites

Molecular and cellular biochemistry, 2020-08, Vol.471 (1-2), p.165-176

2020

Volltextzugriff (PDF)

Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction–Induced Cardiac Hypertrophy in Rats

Journal of cardiovascular pharmacology, 2022-06, Vol.79 (6), p.833-845

2022

Volltextzugriff (PDF)

Identification of 19-( S/R )Hydroxyeicosatetraenoic Acid as the First Endogenous Noncompetitive Inhibitor of Cytochrome P450 1B1 with Enantioselective Activity

Drug metabolism and disposition, 2019-02, Vol.47 (2), p.67-70

2019

Volltextzugriff (PDF)

16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism

Molecular and cellular biochemistry, 2024-06, Vol.479 (6), p.1379-1390

2024

Volltextzugriff (PDF)

Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy

Journal of pharmaceutical sciences, 2020-07, Vol.109 (7), p.2321-2335

2020

Volltextzugriff (PDF)

Cytochrome P450-derived eicosanoids and inflammation in liver diseases

Prostaglandins & other lipid mediators, 2020-04, Vol.147, p.106400-106400, Article 106400

2020

Volltextzugriff (PDF)

Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites

Journal of molecular and cellular cardiology, 2018-12, Vol.125, p.162-173

2018

Volltextzugriff (PDF)

Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1

European journal of drug metabolism and pharmacokinetics, 2021-09, Vol.46 (5), p.613-624

2021

Volltextzugriff (PDF)

Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective

Scientific reports, 2015-10, Vol.5 (1), p.15639, Article 15639

2015

Volltextzugriff (PDF)

The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells

European journal of drug metabolism and pharmacokinetics, 2023-11, Vol.48 (6), p.709-722

2023

Volltextzugriff (PDF)

Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles

Emergent materials (Online), 2021-02, Vol.4 (1), p.265-277

2021

Volltextzugriff (PDF)

Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy

Journal of cardiovascular pharmacology, 2017-07, Vol.70 (1), p.16-24

2017

Volltextzugriff (PDF)

Resveratrol Protects Against Angiotensin II‐Induced Cellular Hypertrophy through Inhibition of CYP1B1/Mid‐Chain Hydroxyeicosatetraenoic Acid Mechanism

The FASEB journal, 2019-04, Vol.33 (S1), p.817.3-817.3

2019

Volltextzugriff (PDF)

Fluconazole Protects against Abdominal Aortic Constriction‐Induced Cardiac Hypertrophy

The FASEB journal, 2021-05, Vol.35 (S1), p.n/a, Article fasebj.2021.35.S1.03284

2021

Volltextzugriff (PDF)

Sero-prevalence of camel brucellosis (Camelus dromedarius) and phenotypic characteristics of Brucella melitensis biovar 3 in Shalateen City, Red Sea Governorate, Egypt

African journal of microbiology research, 2017-08, Vol.11 (32), p.1259-1266

2017

Volltextzugriff (PDF)

Nematocidal activity of chitosan nanoparticles conjugated with albendazole against the enteral and parenteral phases of trichinosis in experimentally infected mice

Journal of parasitic diseases, 2024-03, Vol.48 (1), p.141-149

2024

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target

S-Enantiomer of 19-Hydroxyeicosatetraenoic Acid Preferentially Protects Against Angiotensin II-Induced Cardiac Hypertrophy

Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms

Chrysin attenuates testosterone-induced benign prostate hyperplasia in rats

Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states

Resveratrol attenuates angiotensin II-induced cellular hypertrophy through the inhibition of CYP1B1 and the cardiotoxic mid-chain HETE metabolites

Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction–Induced Cardiac Hypertrophy in Rats

Identification of 19-( S/R )Hydroxyeicosatetraenoic Acid as the First Endogenous Noncompetitive Inhibitor of Cytochrome P450 1B1 with Enantioselective Activity

16R-HETE and 16S-HETE alter human cytochrome P450 1B1 enzyme activity probably through an allosteric mechanism

Fluconazole Represses Cytochrome P450 1B1 and Its Associated Arachidonic Acid Metabolites in the Heart and Protects Against Angiotensin II-Induced Cardiac Hypertrophy

Cytochrome P450-derived eicosanoids and inflammation in liver diseases

Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites

Novel Synthetic Analogues of 19(S/R)-Hydroxyeicosatetraenoic Acid Exhibit Noncompetitive Inhibitory Effect on the Activity of Cytochrome P450 1A1 and 1B1

Metformin Attenuates Testosterone-Induced Prostatic Hyperplasia in Rats: A Pharmacological Perspective

The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells

Targeting arachidonic acid–related metabolites in COVID-19 patients: potential use of drug-loaded nanoparticles

Inhibition of Mid-chain HETEs Protects Against Angiotensin II-induced Cardiac Hypertrophy

Resveratrol Protects Against Angiotensin II‐Induced Cellular Hypertrophy through Inhibition of CYP1B1/Mid‐Chain Hydroxyeicosatetraenoic Acid Mechanism

Fluconazole Protects against Abdominal Aortic Constriction‐Induced Cardiac Hypertrophy

Sero-prevalence of camel brucellosis (Camelus dromedarius) and phenotypic characteristics of Brucella melitensis biovar 3 in Shalateen City, Red Sea Governorate, Egypt

Nematocidal activity of chitosan nanoparticles conjugated with albendazole against the enteral and parenteral phases of trichinosis in experimentally infected mice

Suchergebnisse filtern